CD69 and COVID-19: In both mild and severe cases of COVID-19, increased expression of the early activation marker CD69 on MAIT cells and diminished expression of the homing receptor chemokine C-X-C motif receptor 3 (CXCR3) has been reported [71, 87, 88, 90].